Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2016

View Archived Issues

Novo Nordisk announces the launch of Tresiba in the U.S.

A new patent listed and additional orphan drug designation granted for Procysbi in the U.S.

Factor VII deficiency corrected with gene therapy in large animal model

OncoTherapy begins phase Ib trials of peptide vaccine for malignant mesothelioma

Cleveland BioLabs starts a phase II trial of CBLB-612 in the Russian Federation

Novavax announces proposed offering of USD 200 million convertible senior notes

CE Mark for Quidel's Sofia S. pneumoniae Fluorescent Immunoassay

Faron Pharmaceuticals listed in London Stock Exchange AIM market

Living Cell Technologies reports findings from phase I/IIa study of NTCell for Parkinson's disease

FDA approves Dako's PD-L1 IHC 28-8 pharmDx test for use in melanoma

FDA clearance for ChloraDerm antimicrobial film dressing

CMV vaccine is safe and effective in stem cell transplant patients

Study unveils the potential of exosomes as therapeutic agents and delivery system for gene therapies

Ferring Pharmaceuticals and Karolinska Institutet to establish human microbiome research center

Afatinib demonstrates superiority to gefitinib on PFS in LUX-Lung 7 trial

Johnson & Johnson reflects on highlights of fourth quarter 2015

University of Texas System patents mitochondrial GLS1 inhibitors

Transplanted pancreatic beta-like cells exhibited glucose-stimulated insulin secretion in mice

FDA puts Medivation's pidilizumab on clinical hold

BBI-608 plus paclitaxel shows promise for the treatment of refractory pancreatic cancer

Prima BioMed starts phase I study of IMP-321 for the treatment of melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...